Trends in Approvals and Prices of Oncology Drugs in the United States (1990-2013)

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.475
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Analysis of Average Manufacturer Prices of New Drugs Approved in the United States (1990-2012)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Prices Analysis of Osteoporosis Drugs Marketed in the United States (1988-2014)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Deconstructing Household Wealth Trends in the United States, 1983 - 2013

2016English

Prm74 - Clinical Outcome Assessments in Drug Approvals: A Review of Label Claims in the United States and Europe (2013-2017)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Comparative Analysis of HIV Antiretroviral Drugs Approvals and Prices in the US and Saudi Arabia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Genotypic and Epidemiologic Trends of Norovirus Outbreaks in the United States, 2009 to 2013

Journal of Clinical Microbiology
Microbiology
2013English

Trends in Pediatric Central Nervous System Tumor Incidence in the United States, 1998-2013

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2018English

Prm98 - Factors Associated With the Incidence of Oncology Drugs Shortages in the United States (2001-2017)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Trends in Approvals of New Drugs With Orphan Designation in the Us (1983-2014)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy